Holger Hebart

Infusion of cytomegalovirus (CMV)–specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy

Hermann Einsele, Eddy Roosnek, Nathalie Rufer et al. · Blood · 2002 · 701 citations · Full text

Life Sciences, Immunology, Infectious Diseases +14

Detection and identification of fungal pathogens in blood by using molecular probes

Hermann Einsele, Holger Hebart, Genève Roller et al. · Journal of Clinical Microbiology · 1997 · 587 citations · Full text

Life Sciences, Microbiology, Molecular Biology +15

Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation

H Einsele, Gerhard Ehninger, Holger Hebart et al. · Blood · 1995 · 454 citations · Full text

Veterinary Medicine, Hematology, Infectious Diseases +16

Resistance to fluconazole and cross‐resistance to amphotericin B in <i>Candida albicans</i> from AIDS patients caused by defective sterol Δ^5,6‐desaturation

Steven L. Kelly, David C. Lamb, Diane Kelly et al. · FEBS Letters · 1997 · 356 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants

Rüdiger Hehlmann, Michael Lauseker, Susanne Saußele et al. · Leukemia · 2017 · 339 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13